Silence Therapeutics, Plc. financial statements, including revenue, expenses, profit, and loss

The total revenue of SLNCF for the last quarter is 1.53 M USD, and it's 101.98% higher compared to the previous quarter. The net income of Q3 24 is -36.12 M USD.